Therapeutic targets in systemic sclerosis

Por Denton, Christopher P
Publicado em 2007

Advances in pathogenesis and treatment of systemic sclerosis

Por Denton, Christopher P
Publicado no Clin Med (Lond) (2016)

Evidence-based Management of Rapidly Progressing Systemic Sclerosis

Por Khanna, Dinesh, Denton, Christopher P.
Publicado em 2010

Case studies in systemic sclerosis

Por Silver, Richard M., Denton, Christopher P.
Publicado em 2011

Old medications and new targeted therapies in systemic sclerosis

Por Nagaraja, Vivek, Denton, Christopher P., Khanna, Dinesh
Publicado no Rheumatology (Oxford) (2015)

Scleroderma : From pathogenesis to comprehensive management /

Por Varga, John., Denton, Christopher P., Wigley, Fredrick M.
Publicado em 2012

Management of systemic sclerosis

Por Ong, Voon H, Brough, Geraldine, Denton, Christopher P
Publicado no Clin Med (Lond) (2005)

Sixth International Workshop on Scleroderma Research, Oxford, UK, 30 July–2 August 2000

Por Wollheim, Frank A, Denton, Christopher P, Abraham, David J
Publicado em 2001

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

Por Gilbane, Adrian J, Denton, Christopher P, Holmes, Alan M
Publicado em 2013

Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin

Por Nikitorowicz-Buniak, Joanna, Denton, Christopher P., Abraham, David, Stratton, Richard
Publicado no PLoS One (2015)

Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue disease

Por Rubin, Lewis J, Black, Carol M, Denton, Christopher P, Seibold, James R
Publicado em 2007

Systemic sclerosis and related connective tissue diseases: present and future

Por Rubin, Lewis J, Black, Carol M, Denton, Christopher P, Seibold, James R
Publicado em 2007

Pericytes display increased CCN2 expression upon culturing

Por Shiwen, Xu, Rajkumar, Vineeth, Denton, Christopher P., Leask, Andrew, Abraham, David J.
Publicado em 2009

Ligand-Dependent Genetic Recombination in Fibroblasts : A Potentially Powerful Technique for Investigating Gene Function in Fibrosis

Por Zheng, Bing, Zhang, Zhaoping, Black, Carol M., de Crombrugghe, Benoit, Denton, Christopher P.
Publicado em 2002

Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon

Por Kundu, Devi, Abraham, David, Black, Carol M., Denton, Christopher P., Bruckdorfer, K. Richard
Publicado no Vascul Pharmacol (2014)

Elevated CCN2 expression in scleroderma: a putative role for the TGFβ accessory receptors TGFβRIII and endoglin

Por Holmes, Alan M., Ponticos, Markella, Shi-wen, Xu, Denton, Christopher P., Abraham, David J.
Publicado em 2011

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

Por Rajkumar, Vineeth S, Howell, Kevin, Csiszar, Katalin, Denton, Christopher P, Black, Carol M, Abraham, David J
Publicado em 2005

Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma

Por Derrett-Smith, Emma C, Dooley, Audrey, Khan, Korsa, Shi-wen, Xu, Abraham, David, Denton, Christopher P
Publicado em 2010

Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohor...

Por Allanore, Yannick, Denton, Christopher P, Krieg, Thomas, Cornelisse, Peter, Rosenberg, Daniel, Schwierin, Barbara, Matucci-Cerinic, Marco
Publicado no Ann Rheum Dis (2016)

Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry

Por Matucci-Cerinic, Marco, Krieg, Thomas, Guillevin, Loic, Schwierin, Barbara, Rosenberg, Daniel, Cornelisse, Peter, Denton, Christopher P
Publicado no Ann Rheum Dis (2016)